Merck Acquires Millipore to Advance its Life Sciences Business
PharmaDeals Analyst
Abstract
Merck has announced the acquisition of all shares of Millipore Corporation for US$ 7.2 B in a strategic shift to increase diversification from pharmaceuticals and strengthen its chemicals business.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.